{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:59:53Z","timestamp":1761512393640},"reference-count":127,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,11]]},"DOI":"10.1097\/qad.0b013e3280adc91e","type":"journal-article","created":{"date-parts":[[2007,4,23]],"date-time":"2007-04-23T08:03:18Z","timestamp":1177315398000},"page":"895-904","source":"Crossref","is-referenced-by-count":44,"title":["The role of adipokines in relation to HIV lipodystrophy"],"prefix":"10.1097","volume":"21","author":[{"given":"Laura L","family":"Sweeney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoife M","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos S","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210130","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R2-1-20210130","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"R3-1-20210130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","volume":"88","author":"Addy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-1-20210130","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R5-1-20210130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/514638","article-title":"Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients","volume":"27","author":"Miller","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1468-1293.2001.00073.x","article-title":"The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition","volume":"2","author":"Carter","year":"2001","journal-title":"HIV Med"},{"issue":"Suppl 4","key":"R7-1-20210130","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/01.aids.0000191485.92285.c7","article-title":"Self-perception of body changes in persons living with HIV\/AIDS: prevalence and associated factors","volume":"19","author":"Santos","year":"2005","journal-title":"AIDS"},{"key":"R8-1-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"R9-1-20210130","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R10-1-20210130","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1086\/317477","article-title":"Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidemiologie Clinique du Syndrome d'Immunodeficience Acquise en Aquitaine","volume":"31","author":"Thiebaut","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R11-1-20210130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-200305020-00005","article-title":"Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy","volume":"17","author":"Mallon","year":"2003","journal-title":"AIDS"},{"key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"R13-1-20210130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00042560-200208010-00010","article-title":"Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort","volume":"30","author":"Heath","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study","volume":"160","author":"Tsiodras","year":"2000","journal-title":"Arch Intern Med"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R16-1-20210130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2013association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"R17-1-20210130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00126334-200105010-00005","article-title":"Lipodystrophy in HIV-infected children is associated with high viral load and low CD4+ -lymphocyte count and CD4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine","volume":"27","author":"Arpadi","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-1-20210130","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/00002030-200009290-00008","article-title":"Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children","volume":"14","author":"Jaquet","year":"2000","journal-title":"AIDS"},{"key":"R19-1-20210130","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1542\/peds.114.2.e235","article-title":"Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens","volume":"114","author":"Taylor","year":"2004","journal-title":"Pediatrics"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200304150-00003","article-title":"Increased lipodystrophy is associated with increased exposure to highly active antiretroviral therapy in HIV-infected children","volume":"32","author":"Vigano","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.qai.0000178930.93033.f2","article-title":"Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children","volume":"40","author":"Beregszaszi","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-1-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","article-title":"Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group","volume":"37","author":"Dube","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/380790","article-title":"Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study","volume":"38","author":"McComsey","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R24-1-20210130","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00002030-200304001-00017","article-title":"HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management","volume":"17","author":"Carr","year":"2003","journal-title":"AIDS"},{"key":"R25-1-20210130","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"R26-1-20210130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7827(02)00046-2","article-title":"Effects of HIV protease inhibitor therapy on lipid metabolism","volume":"42","author":"Hui","year":"2003","journal-title":"Prog Lipid Res"},{"key":"R27-1-20210130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/nm1201-1327","article-title":"HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia","volume":"7","author":"Liang","year":"2001","journal-title":"Nat Med"},{"key":"R28-1-20210130","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy","volume":"12","author":"Shimomura","year":"1998","journal-title":"Genes Dev"},{"issue":"Suppl 2","key":"R29-1-20210130","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome","volume":"30","author":"Carr","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R30-1-20210130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/joe.0.1720155","article-title":"The HIV protease inhibitor saquinavir impairs lipid metabolism and glucose transport in cultured adipocytes","volume":"172","author":"Ranganathan","year":"2002","journal-title":"J Endocrinol"},{"key":"R31-1-20210130","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"R32-1-20210130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","article-title":"Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity","volume":"22","author":"Kakuda","year":"2000","journal-title":"Clin Ther"},{"key":"R33-1-20210130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.189.1.51","article-title":"The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor","volume":"189","author":"Kino","year":"1999","journal-title":"J Exp Med"},{"key":"R34-1-20210130","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1128\/JVI.76.19.9724-9734.2002","article-title":"Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300\/CBP coactivators","volume":"76","author":"Kino","year":"2002","journal-title":"J Virol"},{"key":"R35-1-20210130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00042560-200208010-00002","article-title":"Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection","volume":"30","author":"Engelson","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R36-1-20210130","first-page":"35","article-title":"Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use","volume":"85","author":"Hadigan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-1-20210130","first-page":"3544","article-title":"Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome","volume":"85","author":"Hadigan","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R38-1-20210130","first-page":"504","article-title":"Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy","volume":"86","author":"Rietschel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-1-20210130","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jcem.87.2.8391","article-title":"Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation","volume":"87","author":"Schwarz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R40-1-20210130","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1089\/088922299309784","article-title":"Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy","volume":"15","author":"Imami","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R41-1-20210130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/bbrc.1996.0587","article-title":"cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)","volume":"221","author":"Maeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"R42-1-20210130","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R43-1-20210130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"R44-1-20210130","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"R45-1-20210130","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.C200251200","article-title":"Disruption of adiponectin causes insulin resistance and neointimal formation","volume":"277","author":"Kubota","year":"2002","journal-title":"J Biol Chem"},{"key":"R46-1-20210130","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","article-title":"Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"106","author":"Okamoto","year":"2002","journal-title":"Circulation"},{"key":"R47-1-20210130","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/en.2003-1336","article-title":"Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans","volume":"145","author":"Fain","year":"2004","journal-title":"Endocrinology"},{"key":"R48-1-20210130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/en.2003-1068","article-title":"A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity","volume":"145","author":"Combs","year":"2004","journal-title":"Endocrinology"},{"key":"R49-1-20210130","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.metabol.2006.02.024","article-title":"Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy","volume":"55","author":"Estrada","year":"2006","journal-title":"Metabolism"},{"key":"R50-1-20210130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.metabol.2004.08.022","article-title":"Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy","volume":"54","author":"Chaparro","year":"2005","journal-title":"Metabolism"},{"key":"R51-1-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1203\/01.pdr.0000228335.64894.26","article-title":"Serum adiponectin and leptin concentrations in HIV-infected children with fat redistribution syndrome","volume":"60","author":"Verkauskiene","year":"2006","journal-title":"Pediatr Res"},{"key":"R52-1-20210130","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu","year":"2004","journal-title":"Antivir Ther"},{"key":"R53-1-20210130","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"R54-1-20210130","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.2337\/diabetes.51.10.2968","article-title":"The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects","volume":"51","author":"Yu","year":"2002","journal-title":"Diabetes"},{"key":"R55-1-20210130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diabetes.52.3.667","article-title":"Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy","volume":"52","author":"Phillips","year":"2003","journal-title":"Diabetes"},{"key":"R56-1-20210130","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/427697","article-title":"Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2 x 2 factorial, randomized, double-blinded, placebo-controlled trial","volume":"40","author":"Gavrila","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R57-1-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-143-5-200509060-00009","article-title":"Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial","volume":"143","author":"van Wijk","year":"2005","journal-title":"Ann Intern Med"},{"key":"R58-1-20210130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"R59-1-20210130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2796.2004.01306.x","article-title":"The current biology of resistin","volume":"255","author":"Steppan","year":"2004","journal-title":"J Intern Med"},{"key":"R60-1-20210130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI20785","article-title":"Adenovirus-mediated chronic \u201chyper-resistinemia\u201d leads to in vivo insulin resistance in normal rats","volume":"114","author":"Satoh","year":"2004","journal-title":"J Clin Invest"},{"key":"R61-1-20210130","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1210\/jc.2003-030519","article-title":"Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R62-1-20210130","doi-asserted-by":"crossref","first-page":"25651","DOI":"10.1074\/jbc.C100189200","article-title":"Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists","volume":"276","author":"Way","year":"2001","journal-title":"J Biol Chem"},{"key":"R63-1-20210130","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/jc.2002-021808","article-title":"Serum resistin (FIZZ3) protein is increased in obese humans","volume":"88","author":"Degawa-Yamauchi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-1-20210130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/jc.2003-031121","article-title":"Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus","volume":"89","author":"Youn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R65-1-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/eje.0.1490331","article-title":"Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance","volume":"149","author":"Silha","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"R67-1-20210130","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1210\/jc.2005-0287","article-title":"Resistin levels in human immunodeficiency virus-infected patients with lipoatrophy decrease in response to rosiglitazone","volume":"90","author":"Kamin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R68-1-20210130","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1210\/jc.2005-0742","article-title":"Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome","volume":"90","author":"Barb","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R69-1-20210130","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1210\/jcem.84.11.6234","article-title":"Inhibition of adipocyte differentiation by HIV protease inhibitors","volume":"84","author":"Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R70-1-20210130","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"R71-1-20210130","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1172\/JCI200317490","article-title":"The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men","volume":"111","author":"Chan","year":"2003","journal-title":"J Clin Invest"},{"key":"R72-1-20210130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(05)66830-4","article-title":"Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa","volume":"366","author":"Chan","year":"2005","journal-title":"Lancet"},{"key":"R73-1-20210130","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1073\/pnas.0505429103","article-title":"Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans","volume":"103","author":"Chan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R74-1-20210130","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa040388","article-title":"Recombinant human leptin in women with hypothalamic amenorrhea","volume":"351","author":"Welt","year":"2004","journal-title":"N Engl J Med"},{"key":"R75-1-20210130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpendmet0196","article-title":"Drug insight: the role of leptin in human physiology and pathophysiology\u2014emerging clinical applications","volume":"2","author":"Brennan","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R76-1-20210130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"R77-1-20210130","first-page":"149","article-title":"Leptin and body composition in healthy postmenopausal women","volume":"43","author":"Martini","year":"2001","journal-title":"Panminerva Med"},{"key":"R78-1-20210130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0026-0495(97)90258-4","article-title":"Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity","volume":"46","author":"Yarasheski","year":"1997","journal-title":"Metabolism"},{"key":"R79-1-20210130","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/01.aids.0000189852.21441.2a","article-title":"Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy","volume":"19","author":"Wunder","year":"2005","journal-title":"AIDS"},{"key":"R80-1-20210130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00126334-200212150-00009","article-title":"Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution","volume":"31","author":"Mynarcik","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R82-1-20210130","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ajcn\/79.6.1103","article-title":"Relation of leptin pulse dynamics to fat distribution in HIV-infected patients","volume":"79","author":"Koutkia","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R83-1-20210130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/bbrc.1998.8468","article-title":"Acute and chronic effects of leptin on glucose utilization in lean mice","volume":"245","author":"Harris","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R84-1-20210130","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.2337\/diabetes.50.6.1440","article-title":"Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes","volume":"50","author":"Tanaka","year":"2001","journal-title":"Diabetes"},{"key":"R85-1-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"R86-1-20210130","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI0215001","article-title":"Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy","volume":"109","author":"Petersen","year":"2002","journal-title":"J Clin Invest"},{"key":"R87-1-20210130","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"R88-1-20210130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.120.4.1375","article-title":"Impairment of cell-mediated immunity in mutation diabetic mice (db\/db)","volume":"120","author":"Mandel","year":"1978","journal-title":"J Immunol"},{"key":"R89-1-20210130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ajcn\/33.1.13","article-title":"Cell-mediated immunity in genetically obese C57BL\/6J ob\/ob) mice","volume":"33","author":"Chandra","year":"1980","journal-title":"Am J Clin Nutr"},{"key":"R90-1-20210130","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.4049\/jimmunol.174.6.3137","article-title":"Leptin in immunology","volume":"174","author":"Matarese","year":"2005","journal-title":"J Immunol"},{"key":"R91-1-20210130","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.168.8.4018","article-title":"Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia","volume":"168","author":"Mancuso","year":"2002","journal-title":"J Immunol"},{"key":"R92-1-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1096\/fsb2fasebj.12.1.57","article-title":"Leptin regulates proinflammatory immune responses","volume":"12","author":"Loffreda","year":"1998","journal-title":"FASEB J"},{"key":"R93-1-20210130","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/1071576031000097526","article-title":"Leptin regulates functional capacities of polymorphonuclear neutrophils","volume":"37","author":"Caldefie-Chezet","year":"2003","journal-title":"Free Radic Res"},{"key":"R94-1-20210130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"R95-1-20210130","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1073\/pnas.93.16.8374","article-title":"The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors","volume":"93","author":"Baumann","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"R96-1-20210130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/cimm.2001.1851","article-title":"Human leptin activates PI3K and MAPK pathways in human peripheral blood mononuclear cells: possible role of Sam68","volume":"212","author":"Martin-Romero","year":"2001","journal-title":"Cell Immunol"},{"key":"R97-1-20210130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/cimm.2001.1815","article-title":"Human leptin signaling in human peripheral blood mononuclear cells: activation of the JAK-STAT pathway","volume":"211","author":"Sanchez-Margalet","year":"2001","journal-title":"Cell Immunol"},{"key":"R98-1-20210130","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1172\/JCI6762","article-title":"Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob\/ob mice","volume":"104","author":"Howard","year":"1999","journal-title":"J Clin Invest"},{"key":"R99-1-20210130","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","article-title":"Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects","volume":"84","author":"Ozata","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R100-1-20210130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"key":"R101-1-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00125-005-0041-2","article-title":"Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin","volume":"49","author":"Chan","year":"2006","journal-title":"Diabetologia"},{"key":"R102-1-20210130","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1210\/jc.2005-0780","article-title":"Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation","volume":"90","author":"Canavan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R103-1-20210130","first-page":"1066","article-title":"A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty","volume":"82","author":"Mantzoros","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R104-1-20210130","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.0308767101","article-title":"Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults","volume":"101","author":"Licinio","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R105-1-20210130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.metabol.2004.08.021","article-title":"The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients","volume":"54","author":"Musso","year":"2005","journal-title":"Metabolism"},{"key":"R106-1-20210130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction","volume":"392","author":"Clement","year":"1998","journal-title":"Nature"},{"key":"R107-1-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1677\/joe.0.1590079","article-title":"Leptin alters the response of the growth hormone releasing factor\u2013growth hormone\u2013insulin-like growth factor-I axis to fasting","volume":"159","author":"LaPaglia","year":"1998","journal-title":"J Endocrinol"},{"key":"R108-1-20210130","first-page":"R110","article-title":"Studies on hypothermia and thyroid function in the obese (ob\/ob) mouse","volume":"233","author":"Ohtake","year":"1977","journal-title":"Am J Physiol"},{"issue":"6","key":"R109-1-20210130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.aids.0000218549.85081.8f","article-title":"Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution","volume":"20","author":"Koutkia","year":"2006","journal-title":"AIDS"},{"key":"R110-1-20210130","first-page":"727","article-title":"Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure","volume":"82","author":"Johannsson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R111-1-20210130","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-199910220-00013","article-title":"Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV","volume":"13","author":"Wanke","year":"1999","journal-title":"AIDS"},{"key":"R112-1-20210130","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1530\/eje.1.02039","article-title":"GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study","volume":"153","author":"Luzi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"R113-1-20210130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.292.2.210","article-title":"Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial","volume":"292","author":"Koutkia","year":"2004","journal-title":"JAMA"},{"key":"R114-1-20210130","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.aids.0000180099.35146.30","article-title":"A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation","volume":"19","author":"Falutz","year":"2005","journal-title":"AIDS"},{"key":"R115-1-20210130","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1073\/pnas.0505429103","article-title":"Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans","volume":"103","author":"Chan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R116-1-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00126334-200205010-00020","article-title":"Bone mineral density abnormalities in patients with HIV infection","volume":"30","author":"Gold","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R117-1-20210130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00002030-200104130-00022","article-title":"Osteopenia in HIV-infected patients: is it the disease or is it the treatment?","volume":"15","author":"Knobel","year":"2001","journal-title":"AIDS"},{"key":"R118-1-20210130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/aid.2006.22.125","article-title":"Ethnic variations in the prevalence of metabolic bone disease among HIV-positive patients with lipodystrophy","volume":"22","author":"Curtis","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R119-1-20210130","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1210\/jc.2003-031506","article-title":"Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia","volume":"89","author":"Brown","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R120-1-20210130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1086\/341489","article-title":"Prospective, intensive study of metabolic changes associated with 48 weeks of amprenavir-based antiretroviral therapy","volume":"35","author":"Dube","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R121-1-20210130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-0115(00)00152-X","article-title":"Leptin is a potent stimulator of bone growth in ob\/ob mice","volume":"92","author":"Steppan","year":"2000","journal-title":"Regul Pept"},{"key":"R122-1-20210130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/joe.0.1750405","article-title":"Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo","volume":"175","author":"Cornish","year":"2002","journal-title":"J Endocrinol"},{"key":"R123-1-20210130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/jcb.10156","article-title":"Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling","volume":"85","author":"Gordeladze","year":"2002","journal-title":"J Cell Biochem"},{"key":"R124-1-20210130","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1210\/jc.2002-020792","article-title":"Effect of subcutaneous leptin replacement therapy on bone metabolism in patients with generalized lipodystrophy","volume":"87","author":"Simha","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R125-1-20210130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","article-title":"Rosiglitazone in the treatment of HAART-associated lipodystrophy\u2014a randomized double-blind placebo-controlled study","volume":"8","author":"Sutinen","year":"2003","journal-title":"Antivir Ther"},{"key":"R126-1-20210130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"R127-1-20210130","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann Intern Med"},{"key":"R128-1-20210130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00126334-200210010-00006","article-title":"Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study","volume":"31","author":"Gelato","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R129-1-20210130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/00002030-200303280-00022","article-title":"Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy","volume":"17","author":"Calmy","year":"2003","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200705110-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T15:03:38Z","timestamp":1683817418000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200705110-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,11]]},"references-count":127,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3280adc91e","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5,11]]}}}